Search

everythinglearnresearchcommunity

for

Search:↓

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Platelet-derived bio-products help in wound healing and tissue regeneration but lack standardized methods, and their use in medicine is growing.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Androgen use may increase the risk of stroke, but more research is needed.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Bald men may have higher heart disease risk.

Transplanting hair follicles into chronic ulcers helps them heal better.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

Baldness may indicate higher heart disease risk in men.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.